JP2021534089A5 - - Google Patents

Info

Publication number
JP2021534089A5
JP2021534089A5 JP2021505956A JP2021505956A JP2021534089A5 JP 2021534089 A5 JP2021534089 A5 JP 2021534089A5 JP 2021505956 A JP2021505956 A JP 2021505956A JP 2021505956 A JP2021505956 A JP 2021505956A JP 2021534089 A5 JP2021534089 A5 JP 2021534089A5
Authority
JP
Japan
Prior art keywords
composition
composition according
bacterial strain
immunodeficiency
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021505956A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534089A (ja
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed filed Critical
Priority claimed from PCT/EP2019/072181 external-priority patent/WO2020035623A1/en
Publication of JP2021534089A publication Critical patent/JP2021534089A/ja
Publication of JP2021534089A5 publication Critical patent/JP2021534089A5/ja
Pending legal-status Critical Current

Links

JP2021505956A 2018-08-17 2019-08-19 細菌株を含む組成物 Pending JP2021534089A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
EP18189521.0 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GB1817648.7 2018-10-29
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GB1900335.9 2019-01-10
GB1901203.8 2019-01-29
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
PCT/EP2019/072181 WO2020035623A1 (en) 2018-08-17 2019-08-19 Compositions comprising bacterial strains

Publications (2)

Publication Number Publication Date
JP2021534089A JP2021534089A (ja) 2021-12-09
JP2021534089A5 true JP2021534089A5 (https=) 2022-08-29

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021505956A Pending JP2021534089A (ja) 2018-08-17 2019-08-19 細菌株を含む組成物

Country Status (14)

Country Link
US (1) US20210330786A1 (https=)
EP (1) EP3836945A1 (https=)
JP (1) JP2021534089A (https=)
KR (1) KR20210046007A (https=)
CN (1) CN113423413A (https=)
AU (1) AU2019322090A1 (https=)
BR (1) BR112021002917A2 (https=)
CA (1) CA3108235A1 (https=)
IL (1) IL280895A (https=)
MA (1) MA53228A (https=)
MX (1) MX2021001888A (https=)
SG (1) SG11202101580TA (https=)
TW (1) TW202023590A (https=)
WO (1) WO2020035623A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用
CN119144528B (zh) * 2024-11-20 2025-06-06 青岛诺和诺康生物科技有限公司 两歧双歧杆菌及其改善哮喘及组胺不耐受的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
CN101595133B (zh) 2006-10-27 2012-11-14 比利时胶囊公司 羟丙基甲基纤维素硬胶囊及制备方法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 ｌｍｃ５２０ 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
AU2015244700B2 (en) * 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
NZ737752A (en) * 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
KR102844378B1 (ko) 2016-05-31 2025-08-07 모리나가 뉴교 가부시키가이샤 뇌기능 개선제

Similar Documents

Publication Publication Date Title
US20240252615A1 (en) Pre-immunization and immunotherapy
Münz Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
JP2021518414A5 (https=)
US9127284B2 (en) Modified bacteria and their uses thereof for the treatment of cancer or tumor
JP2021534089A5 (https=)
JP2022101658A5 (https=)
JP2020511160A (ja) 組み換え単純ヘルペスウイルス及びその使用
US11725183B2 (en) Method of culturing segmented filamentous bacteria in vitro
US20220331385A1 (en) Anti-cancer oncolytic virus combination therapies and elite responder selection platforms
JP2019520061A5 (https=)
JP2018522041A5 (https=)
WO2020000562A1 (zh) 阿克曼粘细菌或普氏菌在制备用于增强抗肿瘤免疫功能的药物中的应用
EP3493823A1 (en) Postbiotic-based composition for treatment of ocular inflammation
Sokke Umeshappa et al. CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination
Bhadra et al. Absence of both IL-7 and IL-15 severely impairs the development of CD8+ T cell response against Toxoplasma gondii
CN117018036A (zh) 巨球形菌属细菌在制备治疗癌症的药物中的应用
Pandya et al. Reprogramming immune response with capsid-optimized AAV6 vectors for immunotherapy of cancer
WO2017222295A1 (ko) 김치 및 된장 유래 젖산균을 유효성분으로 포함하는 인플루엔자 바이러스 예방 및 치료용 조성물
Wang et al. Establishment and application of target gene disruption system in Saccharomyces boulardii
JP5699093B2 (ja) パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物
CN110982841A (zh) 重组腺相关病毒载体、重组腺相关病毒aav8-pd1及其应用
CN113069547B (zh) Bap1作为肿瘤治疗靶点在制备预防或治疗肿瘤药物中的应用
KR20250082868A (ko) 분비형 코리스메이트 뮤테이즈 (Rv1885c)가 약화된 Mycobacterium bovis BCG 균주, 이를 포함하는 백신용 조성물 및 이의 용도
KR102135328B1 (ko) 결핵 2가 항원을 발현하는 약독화된 재조합 백시니아 바이러스 및 이를 포함하는 결핵 예방용 조성물
CN119709635A (zh) 一种单纯疱疹病毒株及其用途